Malin Corporation plc

Research Malin Corporation plc (MLC) on Bullrun: market cap EUR 30.35M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 30.35M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2024EUR 0EUR 0-EUR 1.30Mn/an/aEUR 62.10MEUR 0EUR 193.20M
FY2023EUR 0EUR 0-EUR 3.20Mn/a0EUR 29.30MEUR 100.00KEUR 109.50M
FY2022EUR 0EUR 12.90M-EUR 7.20Mn/a0.38EUR 173.90MEUR 100.00KEUR 283.10M
FY2021EUR 0EUR 37.80M-EUR 6.20Mn/a0.85EUR 32.70MEUR 100.00KEUR 218.90M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-23EUR 30.35Mn/an/an/a

About Malin Corporation plc

Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Malin Corporation plc's market cap?

Malin Corporation plc's market capitalization is EUR 30.35M.

What does Malin Corporation plc do?

Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.